Original Article
You have full text access to this OnlineOpen article
Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510290352
Copyright © 1999 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Chan, H. L. Y., Hussain, M. and Lok, A. S. F. (1999), Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology, 29: 976–984. doi: 10.1002/hep.510290352
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 30 NOV 1998
- Manuscript Received: 12 AUG 1998
Funded by
- Hong Kong Association for the Study of Liver Diseases (to Dr. Chan) and a VA Merit Review Award (to Dr. Lok)
References
- 1, , , , , , , et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990; 99:1113–1119.MEDLINE
- 2
- 3, , , , , , . Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii:588–590.
- 4
- 5, , , , , , , et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64:1298–1303.MEDLINE
- 6, , , , , , . Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 1990; 12:1284–1289.MEDLINE
- 7, , , , , , , et al. Changes in the prevalence of HBeAg-negative mutants hepatitis B virus during the course of chronic hepatitis B. Hepatology 1994; 20:8–14.MEDLINE
- 8, , , , , . Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993; 67:5402–5410.MEDLINE
- 9, , , , , , . Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995; 22:1641–1647.MEDLINE
- 10, , . Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus—large-scaled analysis using a new genotyping method. J Infect Dis 1997; 175:1285–1293.MEDLINE
- 11, , . Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance. Hepatology 1995; 21:19–24.MEDLINE
- 12, , , , , , , et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68:8102–8110.MEDLINE
- 13, , . Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease. J Gen Virol 1997; 78:1469–1478.MEDLINE
- 14, , , , , , , et al. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B. J Med Virol 1996; 49:115–123.MEDLINE
- 15, , , , , . Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J Med Virol 1994; 44:96–103.MEDLINE
- 16, , , , . Effects of a naturally occurring mutation in the hepatitis virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70:5845–5851.MEDLINE
- 17, , . Biological properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 1997; 233:374–381.MEDLINE
- 18, , . Wild type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653)-T, A(1762) -T, and G(1764)-A mutations in the core promoter. J Gen Virol 1998; 79:375–380.MEDLINE
- 19, , , . Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 1996; 226:269–280.MEDLINE
- 20, , , , , , , et al. Mutations in the core promoter/enhancer II regions of naturally occurring hepatitis B virus variants and analysis of the effects on transcription activities. Intervirology 1995; 38:290–294.MEDLINE
- 21, , , , . A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324:1705–1709.MEDLINE
- 22, , , , . Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324:1699–1704.MEDLINE
- 23, , . Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992; 16:1338–1342.MEDLINE
- 24, , . Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members. Hepatology 1994; 19:1366–1370.MEDLINE
- 25, , , , , , , et al. Hepatitis B virus strain with mutation in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122:241–248.MEDLINE
- 26, , , . Long-term follow-up in a randomized controlled trial of recombinant alpha-interferon in Chinese patients with chronic hepatitis B infection. Lancet 1988; 2:298–302.MEDLINE
- 27, , , , , , , et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102:2091–2097.MEDLINE
- 28, , , . Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 1997; 78:2055–2065.MEDLINE
- 29, , , . Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995; 109:1618–1623.MEDLINE
- 30, . A revised secondary structure model for the 3′-end of hepatitis B virus pregenomic RNA. Nucleic Acids Res 1996; 24:3295–3301.MEDLINE

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)